Pernelle Lavaud

Pernelle Lavaud

UNVERIFIED PROFILE

Are you Pernelle Lavaud?   Register this Author

Register author
Pernelle Lavaud

Pernelle Lavaud

Publications by authors named "Pernelle Lavaud"

Are you Pernelle Lavaud?   Register this Author

19Publications

354Reads

16Profile Views

Studying Rarity in Bladder Cancer.

Eur Urol 2020 Apr 5;77(4):447-448. Epub 2019 Dec 5.

Department of Cancer Medicine, Gustave Roussy, Cancer Campus, Grand Paris, Université Paris-Sud, Université Paris-Saclay, Villejuif, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2019.11.018DOI Listing
April 2020

Liver tests increase on abiraterone acetate in men with metastatic prostate cancer: Natural history, management and outcome.

Eur J Cancer 2020 Apr 6;129:117-122. Epub 2020 Mar 6.

Gustave Roussy, Université Paris-Saclay, Oncology Medicine Department, Villejuif, F-94805, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2020.01.017DOI Listing
April 2020

[Management of metastatic testicular germ cell tumors].

Bull Cancer 2019 Oct 26;106(10):896-902. Epub 2019 Aug 26.

Université Paris-Saclay, Gustave-Roussy, Department of Cancer Medicine, 114, rue Edouard-Vaillant, Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bulcan.2019.05.004DOI Listing
October 2019

Long-term complete remission with Ipilimumab in metastatic castrate-resistant prostate cancer: case report of two patients.

J Immunother Cancer 2017 18;5:31. Epub 2017 Apr 18.

Institut Gustave Roussy, University of Paris-Sud, Department of Cancer Medicine, 114 Rue Edouard Vaillant, 94800 Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s40425-017-0232-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5394619PMC
June 2018

Durvalumab in urothelial cancers.

Expert Rev Anticancer Ther 2018 04 5;18(4):311-318. Epub 2018 Mar 5.

b Drug Development Department (DITEP), Gustave Roussy , Université Paris-Sud, Université Paris-Saclay , Villejuif , France.

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/14737140.2018.1
Publisher Site
http://dx.doi.org/10.1080/14737140.2018.1443812DOI Listing
April 2018

Atezolizumab in urothelial bladder carcinoma.

Future Oncol 2018 Feb 14;14(4):331-341. Epub 2017 Nov 14.

Department de Médecine Oncologique & INSERM U981, Gustave Roussy, Université Paris-Saclay, 94805, Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon-2017-0433DOI Listing
February 2018

[Atezolizumab (Tecentriq): Activity, indication and modality of use in advanced or metastatic urinary bladder carcinoma].

Bull Cancer 2018 Feb 28;105(2):140-145. Epub 2017 Dec 28.

University of Paris Sud, Gustave Roussy cancer campus, drug development department, 94805 Villejuif cedex, France; University of Paris Sud, Gustave Roussy cancer campus, department of medical oncology, 94805 Villejuif cedex, France. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00074551173038
Publisher Site
http://dx.doi.org/10.1016/j.bulcan.2017.10.030DOI Listing
February 2018

[ESMO ECCO 2015: The highlights of immunotherapy and targeted therapies].

Bull Cancer 2016 Jun 24;103(6):594-603. Epub 2016 May 24.

AERIO, 149, avenue du Maine, 75014 Paris, France; DITEP, Gustave-Roussy, 94805 Villejuif, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bulcan.2016.04.001DOI Listing
June 2016